Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration

E-ISSN： 1873-5576|13|4|444-459

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.4, 2013-05, pp. : 444-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer

By Twiddy Alexis Leon Carlos Wasan Kishor

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 423-437

Springer Publishing Company

Access to resources Recommend Favorite

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: In Metastatic Castration-Resistant Prostate Cancer

By Yang Lily P.H.

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2067-2077

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Theraputic Strategies for Castration-resistant Prostate Cancer: Update and Future Perspectives)

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 2-5

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Therapeutic Strategies for Castration-resistant Prostate Cancer: Update and Future Perspectives)

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 2-5

Bentham Science Publishers

Access to resources Recommend Favorite